CollPlant Biotechnologies (CLGN) vs Soligenix (SNGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Soligenix is the larger company by market cap ($7.5 million vs $7.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLGN | SNGX |
|---|---|---|
| Share price | $3.97 | $0.3466 |
| Market cap | $7.51M | $7.54M |
| 1-day change | +14.74% | -1.95% |
| EPS (TTM) | $-10.74 | $-0.79 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.80 | $1.97 |
| 52-week low | $2.64 | $0.28 |
| Distance from 52-week high | -85.19% | -82.41% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +298.15% |
| Average volume | 351.98K | 253.75K |
| Shares outstanding | 1.89M | 21.77M |
| Employees | 39 | 13 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CollPlant Biotechnologies
CLGN stock →CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology.
Healthcare · Biotechnology · 39 employees
About Soligenix
SNGX stock →Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions.
Healthcare · Biotechnology · 13 employees
CLGN vs SNGX FAQ
Which is bigger, CollPlant Biotechnologies or Soligenix?
Soligenix (SNGX) is larger, with a market capitalization of $7.54M compared with $7.51M for CollPlant Biotechnologies (CLGN).
Are CollPlant Biotechnologies and Soligenix in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.